LDS/Medical Tests/Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Anti-CCP, which is also termed anti-citrullinated protein/peptide antibodies (ACPAs), is a test used for the detection of autoantibodies in human serum or plasma towards cyclic peptide containing modified arginine residues (CCP2 peptides). This test is used as an aid in diagnosis of Rheumatoid Arthritis (RA). Since Anti-CCP is often detected early in the disease process, it is also used to predict severity of disease and irreversible damage. Antibody titer level is used for disease management and as an early predictor of the efficacy of anti-tumor necrosis factor (anti-TNF) therapy. In 2009, anti-CCP was included in the new Criteria for RA diagnosis and management by the American College of Rheumatology.

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic joint inflammation leading to joint destruction and loss of function. Early diagnosis and intervention is vital in preventing irreversible joint damage. The diagnosis of RA is primarily based on clinical, radiological and immunological features. The most common immunological test is the rheumatoid factor (RF) test. Although the RF test has good sensitivity, it is not specific for RA, since it is often present in healthy individuals, other rheumatic disorders and other inflammatory diseases, other autoimmune diseases or chronic infections. Since the specificity of anti-CCP is around 95-98% for RA, the use of anti-CCP antibodies along with the Rheumatoid Factor leads to better diagnosis, disease management and prognosis.

  • As an aid in the diagnosis of Rheumatoid Arthritis
  • Differential diagnosis of Rheumatoid Arthritis from other disorders which don’t meet the American College of Rheumatology (ACR) criteria for RA
  • Disease management and monitoring

Positive

  • Positivity for anti-CCP antibody and Rheumatoid Factor along with appropriate symptoms is indicative of RA
  • Positivity for anti-CCP antibody but not Rheumatoid Factor, with appropriate clinical symptoms might indicate RA; however, this also might indicate early RA or suggest that RA will develop in the future.

Negative

  • Negative anti-CCP antibody with positive Rheumatoid Factor and nonspecific symptoms most likely indicates an undetermined autoimmune disease or inflammatory condition.
  • Negativity for both anti-CCP antibody and Rheumatoid Factor suggests a low probability of having RA.

Negative (Non-reactive)

Enzyme-linked immunosorbent assay (ELISA), Real-time Polymerase Chain Reaction (PCR), Western Blot.

Serum (red top, SST), Plasma (purple top, EDTA)

Stability

  • Ambient: 1-3 days
  • Refrigerated: 7-14 days
C-Reactive Protein, Erythrocyte Sedimentation Rate, Antinuclear Antibody, ANA specific antigen profile, Synovial Fluid Analysis.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login